Pds biotechnology announces conference call and webcast for second quarter 2023 financial results

Princeton, n.j., aug. 07, 2023 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the company's proprietary t cell activating platforms, today announced that the company will release financial results for the second quarter of 2023 on monday, august 14, 2023, before the market opens. following the release, management will host a conference call to review the financial results and provide a business update.
PDSB Ratings Summary
PDSB Quant Ranking